Sigrid Therapeutics Launches the Glucose Stabiliser in the U.S.

Report this content

Designed to Control Blood Sugar and Weight Without Prescriptions, The Glucose Stabiliser is a Natural Silica-Based Solution.

MIAMI, USA - November 14, 2023. Sigrid Therapeutics has officially launched the Glucose Stabiliser, an over-the-counter blood sugar control supplement which reduces caloric intake from fats and carbs. With about 1 in every 10 Americans facing a Type 2 Diabetes diagnosis and the ever-growing popularity of a class of drugs used for weight loss for the general population, Sigrid’s strategic launch into the U.S. market could not have come at a better time.

The supplement, taken before your two biggest meals of the day, comes after over 10 years of research when Co-Founder, Professor Tore Bengtsson, discovered improvements in metabolic disorder measurements after ingesting engineered silica particles. The technology is 100% natural since it is made of one of the most abundant resources on the planet, silica.

The Glucose Stabiliser contains patented SiPore® technology discovered in 2008 that has proven to lower blood sugar, minimize bloating, keep you feeling fuller for longer, curb appetite, and aid weight loss. Clinical research shows users with Type 2 Diabetes saw a 40% larger HbA1c reduction compared to Metformin in half the time.

Composed of micron-sized silica particles that work inside the gut and nowhere else, the particles act as a molecular sieve by mechanically separating digestive enzymes from undigested food. The captured enzymes are responsible for breaking down complex carbohydrates and fats, which, slows down food digestion. With a slower digestion process, those using the Glucose Stabiliser can expect to feel full for longer, lose weight and lower their cholesterol, all while continuing to live their lives to the fullest without restriction. While many prescribed diabetes medications come with a long list of side effects, the Glucose Stabiliser is very well tolerated. The SiPore® technology is generally recognized as safe (GRAS), affirming its safety for use in promoting a slower digestion process and supporting weight management without imposing restrictions on daily life.

While the diabetic implications are considerable, it’s also an excellent option for non-diabetics who would be interested in trying out the popular weight-loss prescriptions but are put off by the cost or the needles. By functioning in a similar way without the side effects of the drug in the bloodstream since it’s administered orally and stays in the gut, it is a suitable option for those seeking general wellness and weight loss. Similarly, it’s the perfect companion for those coming off the drugs who fear a rebound weight gain. 

“The Glucose Stabiliser is representative of Sigrid’s mission of empowering those looking to transform their metabolism for the better in an affordable and approachable manner,” said Sana Alajmovic, CEO of Sigrid Therapeutics. “After seeing my father transition from having difficulty controlling his blood sugar to developing Type 2 Diabetes, it is a personal undertaking just as much as it is professional, to develop innovative treatments that allow users to continue living their life to the fullest, without having to drastically change their lifestyle.”

Pricing for the Glucose Stabiliser starts at $99 a bottle and it can now be purchased online at sigridstabiliser.com.

For more information, www.sigridthx.com, or please contact:

Sana Alajmovic, Co-Founder & CEO, Sigrid Therapeutics

Phone +46 72 389 3396,

Email: sana@sigridthx.com

About Sigrid Therapeutics

Sigrid Therapeutics is a Swedish-based biotechnology company dedicated to revolutionizing obesity and diabetes management through its innovative SiPore® technology. The company’s flagship product, SiPore21®, is currently in SHINE clinical trials, offering a natural, non-drug solution for prediabetes progression and weight control. With a focus on impactful innovation, Sigrid Therapeutics is committed to enhancing the well-being of individuals worldwide. For more information visit sigridstabiliser.com.

Subscribe

Media

Media

Quotes

The Glucose Stabiliser is representative of Sigrid’s mission of empowering those looking to transform their metabolism for the better in an affordable and approachable manner. After seeing my father transition from having difficulty controlling his blood sugar to developing Type 2 Diabetes, it is a personal undertaking just as much as it is professional, to develop innovative treatments that allow users to continue living their life to the fullest, without having to drastically change their lifestyle.
Sana Alajmovic, CEO of Sigrid Therapeutics.